Financials
Financial year 2025
MEDPACE BELGIUM from Leuven, company number BE0877865242, closed financial year 2025 with a result of € 753,286 after tax. For that financial year MEDPACE BELGIUM recorded revenue of € 21.6 million and equity of € 3.4 million. Compared with financial year 2024, the result moved from € 672,197 to € 753,286. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 3.4 million
▲ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 753,286
▲ 12% vs 2024
Profit after tax over the fiscal year.
€ 1.5 million
▼ 18% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 3.4 million.
People and assets in 2025
178.2
▲ 7.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 17.7 million
▲ 8% vs 2024
€ 99,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1.3 million
▼ 19% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.7 million
▲ 66% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 156 days on average.
€ 3.6 million
▲ 5% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 16,638,650 | € 19,564,400 | € 21,626,843 | ▲ 11% |
| Gross margin | € 11,264,177 | - | - | - | |
| Profit after taxes | € 339,291 | € 587,672 | € 672,197 | € 753,286 | ▲ 12% |
| Equity | € 1,420,701 | € 2,008,373 | € 2,680,570 | € 3,433,856 | ▲ 28% |
| Total debts | € 4,174,231 | € 4,717,574 | € 4,652,823 | € 5,448,692 | ▲ 17% |
| Cash | € 666,507 | € 1,775,486 | € 1,855,506 | € 1,521,514 | ▼ 18% |
| Retained profit | € 1,408,301 | € 1,995,973 | € 2,666,310 | € 3,419,596 | ▲ 28% |
| Balance sheet total | € 5,594,932 | € 6,725,947 | € 7,333,393 | € 8,882,549 | ▲ 21% |
| Employees (FTE) | 119.8 | 144.4 | 170.4 | 178.2 | ▲ 7.8 |
By revenue, MEDPACE BELGIUM ranks 4th of 9 companies with main activity “Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies” in Leuven that publish figures (fiscal year 2025).
Key figures of MEDPACE BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about MEDPACE BELGIUM the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MEDPACE BELGIUM?
What happened at MEDPACE BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 753,286 (▲ 12% vs 2024). filed late Source: NBB ↗
- John Thomas Wynne II became a director. NBB
- Kevin Michael Brady became a director. NBB
- Brad William Hansman became a director. NBB
- Stephen Paul Ewald became a director. NBB
- New establishment in Leuven. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 339,291 profit in 2022 to € 753,286 profit in 2025.
Paid € 1.2 million in corporate taxes since 2022.
Best year ever: 2025, with € 753,286 profit.
On average € 94,000 of value added per employee in 2022.
Management
Behind MEDPACE BELGIUM are John Thomas Wynne II, Kevin Michael Brady, Stephen Paul Ewald and Brad William Hansman. The shares are held by Medpace Europe Holding BV.
Directors
According to the 2025 annual accounts
John Thomas Wynne II
Director
since 2026
Kevin Michael Brady
Director
since 2026
Stephen Paul Ewald
Director
since 2021
Brad William Hansman
Director
since 2026
Shareholders
Medpace Europe Holding BV
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Technologielaan 11
3001 Leuven
Technologielaan 19
3001 Leuven
Active since 6 November 2006
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Leuven
Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 251 active companies in Leuven, largest first.
€ 64.8 million revenue · 2025
€ 47.9 million revenue · 2024
€ 22.3 million revenue · 2025
€ 3.7 million gross margin · 2025
Tactical Advisory Group Management Services
€ 3.1 million gross margin · 2025
€ 2.6 million gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- GISSLER Alexander Ernst August(oprichter) 100%
Details
- Company number
- 0877.865.242
- VAT number
- BE 0877.865.242
- Registered office
- Technologielaan 11, 3001 Leuven
- Names & denominations
- MEDPACE BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 2005
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Activiteiten van medische beeldvorming en medische laboratoria
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van medische laboratoria